Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
HEICO (HEI) combines high-margin aftermarket parts with a diversified electronics business. Recent beats in both Flight Support Group and Electronic Technologies Group, plus strong free cash flow ($944M), support continued EBITDA compounding. Valuation is rich (EV/EBITDA ~36x, P/E ~60x) so enter with a disciplined stop and a long-term horizon to le…
Nuvectis Pharma saw its stock climb in premarket trading after announcing an exclusive ex-China licensing agreement with Haisco Pharmaceutical Group covering two clinical-stage compounds. The arrangement brings NXP100, a Complement Factor B inhibitor with late-stage data in multiple complement-mediated diseases, and NXP200, an oral brain-penetrant …
Regenxbio said the U.S. Food and Drug Administration has indicated it will reverse a prior decision declining approval of Navsunli, the company’s gene therapy for Hunter syndrome, and that the data already on file could support an accelerated approval application. The company reported a premarket share rise of about 10% following the agency’s signa…
Adobe projects the 12th annual Prime Day will prompt $26.3 billion in online purchases across Amazon and competing retailers over a four-day span, a 9% rise from last year. Walmart and Target will stage simultaneous promotions, while research and market estimates point to strong Prime membership penetration and a large share of U.S. online spending…
Chevron shares climbed in pre-market trading following the announcement of a 20-year power purchase agreement with Microsoft to supply natural-gas-fired electricity to a proposed, large-scale data center campus in West Texas. Market participants highlighted the deal's cash flow profile - explicitly structured to be insulated from oil and gas price …
Amazon’s Prime Day, moved up to June 23-26, will spotlight whether U.S. consumer spending remains resilient or shows strain. The retailer is emphasizing perishables, household basics and back-to-school items, while promoting an AI shopping assistant and preparing for intense competition from Walmart and Target. Analysts and lenders say shoppers are…
A survey of senior U.S. biotechnology leaders finds China has overtaken the United States in the number of clinical drug trials but still trails on several innovation metrics. Respondents said China leads in clinical development and supply chain capabilities, while the U.S. maintains advantages in technology transfer, financing, commercialization a…
Palvella Therapeutics Inc saw its stock climb in premarket trading after the U.S. Food and Drug Administration accepted a rolling review of the company's New Drug Application for QTORIN rapamycin, an investigational therapy for microcystic lymphatic malformations. The rolling review allows incremental submission of completed NDA sections while the …
Wesley T. Pollard, a director at ACCESS Newswire Inc. (NASDAQ: ACCS), executed an open market purchase of 1,000 shares on June 3, 2026, at $6.25 per share, bringing his direct ownership to 11,776 shares. The acquisition follows a significant stock decline and a recent quarterly earnings miss, raising questions about the company's financial trajecto…
Bank of America analysts argue that gold mining stocks are undervalued relative to the current price of bullion. Despite recent declines in the metal driven by a stronger dollar and a more hawkish Federal Reserve posture, BofA’s valuation work suggests shares are pricing gold at a meaningful discount to spot. Central bank demand and longer-term str…
Shares of Praxis Precision Medicines rose after the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to elsunersen for treating seizures tied to SCN2A Developmental and Epileptic Encephalopathy. The designation was based on positive Phase 1/2 EMBRAVE Part A data showing a 77% sham-adjusted reduction in monthly seizures and…
Clearmind Medicine has announced the completion of treatment for all participants in the initial phase (Part A) of its ongoing FDA-regulated Phase I/II clinical trial evaluating CMND-100, a novel therapeutic for Alcohol Use Disorder. The company is analyzing data and plans to proceed to the next stage of clinical development, advancing its non-hall…
Cleveland-Cliffs Inc. (CLF) fell in premarket trading after Morgan Stanley lowered its rating on the stock from Overweight to Equalweight even as the firm raised its steel price outlook. The analyst maintained a $12.50 price target and said much of the upside from high hot-rolled coil prices is already baked into equities, while noting potential up…
ECARX Holdings announced a definitive agreement to acquire the entire Flyme software portfolio for RMB 1.8 billion (about $266 million). The deal transfers 100% of equity in a newly carved-out entity that holds Flyme Auto and Flyme OS, with financing expected to be roughly 70% syndicated 10-year bank loans and 30% internal funding. Management accou…
Fervo Energy said it has partnered with Nvidia and the Pacific Northwest National Laboratory to develop EGS-Twin, a digital twin platform for enhanced geothermal systems. The announcement sent Fervo shares up 11.1% in premarket trading Monday. The initiative will use Fervo’s Nevada and Utah field data, Nvidia AI infrastructure and PNNL high-perform…
Outdoor Holding Company, operator of GunBroker.com, reported a 10.1% revenue increase and significant reduction in operating losses for Q4 and fiscal year 2026, driven by cost reductions, settlement of legacy legal matters, and platform investments including AI enhancements. Adjusted EBITDA more than doubled year-over-year, with improved gross marg…
Verrica Pharmaceuticals announced dosing of the first U.S. patient in the COVE-3 Phase 3 clinical trial evaluating YCANTH® (VP-102) for common warts. With a global Phase 3 program ongoing, including its Japanese partner Torii Pharmaceutical, the company targets a significant market with no current FDA-approved treatments. Positive Phase 2 results a…
Alan Greenspan, who died on Monday at age 100, combined an early musical life with decades in public service and a reputation for enigmatic public remarks. Here are seven concise facts drawn from his personal and professional life, including his artistic background, long-term relationship and marriage, distinctive working habits, ideological friend…
Saudi Arabia's sovereign reserve manager has recently redeemed billions from at least two international asset managers and redirected some of those funds into strategies judged to deliver stronger results and greater liquidity. The redemptions, which began before the start of the Iran war, included a multibillion-dollar pull from passive index-trac…
On June 22 Sinda kicked off its U.S. initial public offering roadshow, seeking a valuation of up to $1.97 billion. The Electrum Group-backed exploration firm is proposing to sell 17.75 million shares at $11.25 to $13.25 each, potentially raising as much as $235.2 million. The offering arrives amid a pickup in new listings, with other companies laun…
AbbVie’s $10.9 billion acquisition of Apogee Therapeutics continues a recent wave of large-scale deals by U.S.-based pharmaceutical and biotechnology firms. Over the past decade, companies have pursued assets across immunology, oncology, neurology, rare diseases, obesity treatments and diagnostics. The list below compiles major transactions reporte…
ITG, a Hendersonville, Tennessee-based digital infrastructure firm owned by Oaktree Capital Management, has filed to list on Nasdaq under the symbol ITG, targeting a valuation of as much as $2.67 billion. The company plans to raise up to $429.3 million by selling 19.5 million shares at $19 to $22 each as part of an active post-SpaceX IPO market. IT…
JPMorgan says battered consumer cyclicals may be forming a bottom and could outperform in the second half of 2026. Analyst Mislav Matejka points to multi-year low price relatives, undemanding valuations and depressed consumer confidence, and highlights catalysts including lower oil prices, reduced tariff rates and the potential for a U.S. consumer …
Upexi, Inc., a Nasdaq-listed company specializing in Solana-based digital asset treasury and consumer brands, announced a private placement raising approximately $19.5 million by issuing over 12 million shares at about $1.60 each. The proceeds are used to reduce existing debt. The offering was made without a placement agent and complies with securi…
Sonoco Products Company, a global leader in sustainable packaging, will report its Q2 2026 financial results on July 22, 2026 after market close, followed by a conference call on July 23. The company highlights its strong operational footprint and recent accolades in sustainability and corporate responsibility.
